Sub-millimetric, patient-specific brain targeting for functional neurosurgery and real-world outcomes in Parkinson’s Disease and Essential Tremor.

We are thrilled to announce that Les Echos has featured RebrAIn for our innovative application of supervised AI in the treatment of Parkinson’s Disease.

The article explores how our AI-driven solutions are revolutionizing Deep Brain Stimulation (DBS) by enhancing precision and patient outcomes. Co-founded by Professor Emmanuel Cuny and Dr. Nejib Zemzemi, RebrAIn continues to push the boundaries of neurosurgical technology.

Learn more about our groundbreaking work by reading the full article in french on Les Echos.

An English translation by Google is available here.